FDA
-
-
-
-
-
-
-
Cosmos Health issues 2026-2029 guidance targeting $200m revenue by 2029
-
-
-
-
-
-
-
Cosmos Health completes Liv18 development, eyes $5M annual revenue
-
-
-
-
-
-
-
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway,
-
-
-
-
-
-
-
Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health
-
-
-
330,098 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

